502 related articles for article (PubMed ID: 9014827)
1. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.
Fleischer J; Soeth E; Reiling N; Grage-Griebenow E; Flad HD; Ernst M
Immunology; 1996 Dec; 89(4):592-8. PubMed ID: 9014827
[TBL] [Abstract][Full Text] [Related]
2. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity.
Fujihara M; Takahashi TA; Azuma M; Ogiso C; Maekawa TL; Yagita H; Okumura K; Sekiguchi S
Blood; 1996 Mar; 87(6):2386-93. PubMed ID: 8630402
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4(+) T cell alloactivation.
Denton MD; Geehan CS; Alexander SI; Sayegh MH; Briscoe DM
J Exp Med; 1999 Aug; 190(4):555-66. PubMed ID: 10449526
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
5. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of B7-1 (CD80) and B7-2 (CD86) costimulatory molecules and dendritic cells on the immune response in leprosy.
Santos DO; Santos SL; Esquenazi D; Nery JA; Defruyt M; Lorré K; Van Heuverswyn H
Nihon Hansenbyo Gakkai Zasshi; 2001 Feb; 70(1):15-24. PubMed ID: 11244783
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of the costimulatory molecules B7-1 (CD80) and B7-2 (CD86) in an in vitro model of the human blood--brain barrier.
Omari KI; Dorovini-Zis K
J Neuroimmunol; 2001 Feb; 113(1):129-141. PubMed ID: 11137584
[TBL] [Abstract][Full Text] [Related]
8. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
Moosig F; Csernok E; Wang G; Gross WL
Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
[TBL] [Abstract][Full Text] [Related]
9. Differential function of CD80- and CD86-transfected human melanoma cells in the presence of IL-12 and IFN-gamma.
Rudy W; Gückel B; Siebels M; Lindauer M; Meuer SC; Moebius U
Int Immunol; 1997 Jun; 9(6):853-60. PubMed ID: 9199968
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes.
Girndt M; Sester U; Kaul H; Hünger F; Köhler H
Transplantation; 1998 Aug; 66(3):370-5. PubMed ID: 9721807
[TBL] [Abstract][Full Text] [Related]
11. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.
Mitra RS; Judge TA; Nestle FO; Turka LA; Nickoloff BJ
J Immunol; 1995 Mar; 154(6):2668-77. PubMed ID: 7533180
[TBL] [Abstract][Full Text] [Related]
12. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity.
Barcy S; Wettendorff M; Leo O; Urbain J; Kruger M; Ceuppens JL; de Boer M
Int Immunol; 1995 Feb; 7(2):179-89. PubMed ID: 7537534
[TBL] [Abstract][Full Text] [Related]
13. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro.
Pettit SJ; Ali S; O'Flaherty E; Griffiths TR; Neal DE; Kirby JA
Clin Exp Immunol; 1999 Apr; 116(1):48-56. PubMed ID: 10209504
[TBL] [Abstract][Full Text] [Related]
15. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
16. Mitogenic stimulation of T cells reveals differing contributions for B7-1 (CD80) and B7-2 (CD86) costimulation.
Perrin PJ; Davis TA; Smoot DS; Abe R; June CH; Lee KP
Immunology; 1997 Apr; 90(4):534-42. PubMed ID: 9176106
[TBL] [Abstract][Full Text] [Related]
17. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
18. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
[TBL] [Abstract][Full Text] [Related]
19. Blocking B7 and CD40 co-stimulatory molecules decreases antiviral T cell activity.
Vermeiren J; Ceuppens JL; Haegel-Kronenberger H; De Boer M; Boon L; Van Gool SW
Clin Exp Immunol; 2004 Feb; 135(2):253-8. PubMed ID: 14738453
[TBL] [Abstract][Full Text] [Related]
20. Expression of the CD80 and CD86 molecules enhances cytotoxicity by human natural killer cells.
Luque I; Reyburn H; Strominger JL
Hum Immunol; 2000 Aug; 61(8):721-8. PubMed ID: 10980383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
